BREAKING NEWS US jobs market blows past expectations, adding 256,000 jobs in December OTC Markets OTCQB - Delayed Quote • USD Argent BioPharma Limited (RGTLF) Follow 0.1860 -0.0140 (-7.00%) At close: January 7 at 3:36:56 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Argent BioPharma Ltd. Raised US$4,500,000 Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology. Argent BioPharma Ltd. Placing to Raise US$4,500,000 Argent BioPharma (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology. Insider Spends AU$1.6m Buying More Shares In Argent BioPharma Those following along with Argent BioPharma Limited ( ASX:RGT ) will no doubt be intrigued by the recent purchase of... Co-Founder of Argent BioPharma Picks Up 3,721% More Stock Investors who take an interest in Argent BioPharma Limited ( ASX:RGT ) should definitely note that the Co-Founder, Roby... Argent BioPharma Full Year 2024 Earnings: AU$0.47 loss per share (vs AU$7.07 loss in FY 2023) Argent BioPharma ( ASX:RGT ) Full Year 2024 Results Key Financial Results Revenue: AU$891.1k (down 74% from FY 2023...